BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 10755614)

  • 1. The ST3Gal-I sialyltransferase controls CD8+ T lymphocyte homeostasis by modulating O-glycan biosynthesis.
    Priatel JJ; Chui D; Hiraoka N; Simmons CJ; Richardson KB; Page DM; Fukuda M; Varki NM; Marth JD
    Immunity; 2000 Mar; 12(3):273-83. PubMed ID: 10755614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and mechanistic features of protein O glycosylation linked to CD8+ T-cell apoptosis.
    Van Dyken SJ; Green RS; Marth JD
    Mol Cell Biol; 2007 Feb; 27(3):1096-111. PubMed ID: 17101770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-galactoside alpha2,3-sialyltransferase-I gene expression during Th2 but not Th1 differentiation: implications for core2-glycan formation on cell surface proteins.
    Grabie N; Delfs MW; Lim YC; Westrich JR; Luscinskas FW; Lichtman AH
    Eur J Immunol; 2002 Oct; 32(10):2766-72. PubMed ID: 12355428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sialyltransferase ST3Gal-I is not required for regulation of CD8-class I MHC binding during T cell development.
    Kao C; Sandau MM; Daniels MA; Jameson SC
    J Immunol; 2006 Jun; 176(12):7421-30. PubMed ID: 16751387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trypanosoma cruzi subverts host cell sialylation and may compromise antigen-specific CD8+ T cell responses.
    Freire-de-Lima L; Alisson-Silva F; Carvalho ST; Takiya CM; Rodrigues MM; DosReis GA; Mendonça-Previato L; Previato JO; Todeschini AR
    J Biol Chem; 2010 Apr; 285(18):13388-96. PubMed ID: 20106975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell activation results in microheterogeneous changes in glycosylation of CD45.
    Hernandez JD; Klein J; Van Dyken SJ; Marth JD; Baum LG
    Int Immunol; 2007 Jul; 19(7):847-56. PubMed ID: 17606981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmentally regulated glycosylation of the CD8alphabeta coreceptor stalk modulates ligand binding.
    Moody AM; Chui D; Reche PA; Priatel JJ; Marth JD; Reinherz EL
    Cell; 2001 Nov; 107(4):501-12. PubMed ID: 11719190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically altered mice with different sialyltransferase deficiencies show tissue-specific alterations in sialylation and sialic acid 9-O-acetylation.
    Martin LT; Marth JD; Varki A; Varki NM
    J Biol Chem; 2002 Sep; 277(36):32930-8. PubMed ID: 12068010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible sialylation: synthesis of cytidine 5'-monophospho-N-acetylneuraminic acid from cytidine 5'-monophosphate with alpha2,3-sialyl O-glycan-, glycolipid-, and macromolecule-based donors yields diverse sialylated products.
    Chandrasekaran EV; Xue J; Xia J; Locke RD; Matta KL; Neelamegham S
    Biochemistry; 2008 Jan; 47(1):320-30. PubMed ID: 18067323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evolution of galactose alpha2,3-sialyltransferase: Ciona intestinalis ST3GAL I/II and Takifugu rubripes ST3GAL II sialylate Galbeta1,3GalNAc structures on glycoproteins but not glycolipids.
    Lehmann F; Kelm S; Dietz F; von Itzstein M; Tiralongo J
    Glycoconj J; 2008 May; 25(4):323-34. PubMed ID: 17973185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression and functional analysis of the sialyl-T antigen in prostate cancer.
    Bai R; Luan X; Zhang Y; Robbe-Masselot C; Brockhausen I; Gao Y
    Glycoconj J; 2020 Aug; 37(4):423-433. PubMed ID: 32583304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for an O-glycan sialylation system in brain. Characterization of a beta-galactoside alpha 2,3-sialyltransferase from rat brain regulating the expression of an alpha-N-acetylgalactosaminide alpha 2,6-sialyltransferase activity.
    Baubichon-Cortay H; Broquet P; George P; Louisot P
    Eur J Biochem; 1989 Jun; 182(2):257-65. PubMed ID: 2472271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T-lymphocyte activation is associated with changes in O-glycan biosynthesis.
    Piller F; Piller V; Fox RI; Fukuda M
    J Biol Chem; 1988 Oct; 263(29):15146-50. PubMed ID: 2971663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 enzyme induces the expression of the α-2,3-sialyltransferase-3 (ST3Gal-I) in breast cancer.
    Sproviero D; Julien S; Burford B; Taylor-Papadimitriou J; Burchell JM
    J Biol Chem; 2012 Dec; 287(53):44490-7. PubMed ID: 23275522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cloning of a novel alpha2,3-sialyltransferase (ST3Gal VI) that sialylates type II lactosamine structures on glycoproteins and glycolipids.
    Okajima T; Fukumoto S; Miyazaki H; Ishida H; Kiso M; Furukawa K; Urano T; Furukawa K
    J Biol Chem; 1999 Apr; 274(17):11479-86. PubMed ID: 10206952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of an alpha2,6-sialyltransferase induced early after lymphocyte activation.
    Kaufmann M; Blaser C; Takashima S; Schwartz-Albiez R; Tsuji S; Pircher H
    Int Immunol; 1999 May; 11(5):731-8. PubMed ID: 10330278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-2, -4, and -15 differentially regulate O-glycan branching and P-selectin ligand formation in activated CD8 T cells.
    Carlow DA; Corbel SY; Williams MJ; Ziltener HJ
    J Immunol; 2001 Dec; 167(12):6841-8. PubMed ID: 11739501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of sialyltransferase CMP-sialic acid:Galbeta1,3GalNAc-R alpha6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas.
    Schneider F; Kemmner W; Haensch W; Franke G; Gretschel S; Karsten U; Schlag PM
    Cancer Res; 2001 Jun; 61(11):4605-11. PubMed ID: 11389097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relative activities of the C2GnT1 and ST3Gal-I glycosyltransferases determine O-glycan structure and expression of a tumor-associated epitope on MUC1.
    Dalziel M; Whitehouse C; McFarlane I; Brockhausen I; Gschmeissner S; Schwientek T; Clausen H; Burchell JM; Taylor-Papadimitriou J
    J Biol Chem; 2001 Apr; 276(14):11007-15. PubMed ID: 11118434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrinsically de-sialylated CD103(+) CD8 T cells mediate beneficial anti-glioma immune responses.
    Jouanneau E; Black KL; Veiga L; Cordner R; Goverdhana S; Zhai Y; Zhang XX; Panwar A; Mardiros A; Wang H; Gragg A; Zandian M; Irvin DK; Wheeler CJ
    Cancer Immunol Immunother; 2014 Sep; 63(9):911-24. PubMed ID: 24893855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.